Home›Companies›Healthcare›IsoBio

IsoBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 14, 2025·Suggest an edit

About IsoBio

IsoBio is a private company based in Gladwyne, Pennsylvania, incorporated in 2025 in Delaware. It has reported $1,722,498 raised in one offering on Form D since November 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 21, 2025Nov 14, 2025$1,722,498of $3.0M target2$861KEquity, Series Seed-2 Preferred StockRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on IsoBio's Form D filed Nov 14, 2025.

TW
Todd Wider
Executive officer, director and promoter
PM
Paul Mann
Director
BT
Bruce Turner
Executive officer, director and promoter

Sources

  1. SECIsoBio, Inc. filing history